AHRQ drug effectiveness research
Initial results of the Agency for Healthcare Research & Quality's comparative effectiveness research mandated by the Medicare Modernization Act will be available in October, Center for Outcomes & Evidence Director Jean Slutsky said. The agency is beginning 12 studies on Medicare "priority conditions" using available data (1"The Pink Sheet" Dec. 20, 2004, p. 11)...
You may also be interested in...
Prescription drug comparative effectiveness research will proceed for 10 "priority conditions," thanks to $15 mil. provided by the fiscal year 2005 omnibus appropriations bill, the Agency for Healthcare Research & Quality said Dec. 15
Three years after rebranding from Concordia, Advanz Pharma is to be swallowed up by European-focused private equity Nordic Capital.
The goal is to create a program which mass sequences SARS-CoV-2 samples in order to detect new variants, with £30m injected into the UK's hub for genomic sequencing in Cambridge.